EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Risk and Associations of Lymphadenopathy in Idiopathic Granulomatous Mastitis: Clinical and Ultrasound Findings from a Cross-Sectional Study

Pardis Javadizadeh, Azim Motamedfar, Mohammad Momen Gharibvand, Zahra Fazelinehad, Elham Farhadi

Archives of Breast Cancer · 2025

DOI: 10.32768/abc.0834408851602 ↗
AbstractBibliografische Angaben

Abstract

Background: Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease posing diagnostic challenges. This study aimed to investigate the risk of lymphadenopathy (LAP) associated with clinical signs, demographic factors, and ultrasound parameters in IGM patients. Methods: This cross-sectional study was conducted at the Breast Clinic of a university-affiliated hospital. Data were collected from the medical records of patients diagnosed with IGM between January and February 2023. Patients with complete medical records and diagnosed with IGM were included. Logistic regression analysis was performed to investigate the association between LAP and clinical signs, demographic factors, and ultrasound parameters. Results: Overall, 140 patients with GM were included in this study. The prevalence of LAP among IGM patients was 20%. The logistic regression analysis revealed a nonsignificant association between LAP and IGM (adjusted OR, 0.823; 95% CI, 0.154–4.39; P=0.819). Similarly, clinical history variables, including age, breastfeeding, breast invasion, and marital status, did not show significant associations with IGM. Conclusion: These findings highlight the complex interplay between clinical and imaging features in IGM, with axillary LAP and nodular LAP emerging as particularly interrelated characteristics.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →